Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Helix BioMedix closes $2.6mm private financing

Executive Summary

Helix BioMedix (developing bioactive peptides for use in topical anti-infectives, wound healing, and dermatological and respiratory conditions) has raised $2.6mm with the private placement of 2.6mm common shares priced at $1 each, a 14% premium. Investors received five-year warrants to buy another 260k common shares with the exercise price of $1.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies